Key Highlights

  • ENvue Medical shares settled down 5% at $0.35.
  • The company set a 1-for-12 reverse split effective September 1, 2026.
  • The split is intended to cut the share count to about 923,718 and help maintain Nasdaq listing.
  • Post-split math on the $0.35 close implies a price in the mid-$4 range before the new basis takes effect.

ENvue Medical (NASDAQ: FEED) shares settled down 5% at $0.35 ahead of a 1-for-12 Reverse Stock Split set for September 1, 2026, intended to cut the share count to about 923,718 and help the company maintain its Nasdaq listing.

What Happened

Reverse splits do not add underlying value; they multiply the share price and shrink the share count so the stock's bid can clear the $1 minimum. Post-split math on the $0.35 close implies a price in the mid-$4 range before the new basis takes effect, assuming the price is not further affected by trading.

Market Reaction

Shares fell modestly, a pattern often seen as some traders exit names ahead of a reverse split intended purely to address listing compliance rather than reflecting any change to the underlying business.

Outlook

Following the September 1 effective date, whether the new post-split price holds above $1 for the required period, and how the smaller post-split float trades, represent the next relevant developments for ENvue Medical's Nasdaq listing status.